Prosthetic Heart Valves-Pipeline Review, 2015

Prosthetic Heart Valves-Pipeline Review, 2015


  • Products Id :- GDME0006EPD
  • |
  • Pages: 309
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Prosthetic Heart Valves-Pipeline Review, 2015

GlobalData's Medical Devices sector report, "Prosthetic Heart Valves-Pipeline Review, 2015" provides an overview of Prosthetic Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key prosthetic heart valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Prosthetic Heart Valves products under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Prosthetic Heart Valves and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Prosthetic Heart Valves under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 16

2 Introduction 17

2.1 Prosthetic Heart Valves Overview 17

3 Products under Development 18

3.1 Prosthetic Heart Valves-Pipeline Products by Stage of Development 18

3.2 Prosthetic Heart Valves-Pipeline Products by Segment 19

3.3 Prosthetic Heart Valves-Pipeline Products by Territory 20

3.4 Prosthetic Heart Valves-Pipeline Products by Regulatory Path 21

3.5 Prosthetic Heart Valves-Pipeline Products by Estimated Approval Date 22

3.6 Prosthetic Heart Valves-Ongoing Clinical Trials 23

4 Prosthetic Heart Valves-Pipeline Products under Development by Companies 24

4.1 Prosthetic Heart Valves Companies-Pipeline Products by Stage of Development 24

4.2 Prosthetic Heart Valves-Pipeline Products by Stage of Development 27

5 Prosthetic Heart Valves Companies and Product Overview 31

5.1 Aegis Surgical Limited Company Overview 31

5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31

5.2 AorTech International plc Company Overview 32

5.2.1 AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32

5.3 Apica Cardiovascular Limited Company Overview 34

5.3.1 Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34

5.4 Boston Children's Hospital Company Overview 35

5.4.1 Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 35

5.5 Boston Scientific Corporation Company Overview 37

5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37

5.6 Braile Biomedica Ltda. Company Overview 46

5.6.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46

5.7 Caisson Interventional, LLC Company Overview 48

5.7.1 Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.8 Cardiac Dimensions, Inc. Company Overview 49

5.8.1 Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.9 CardiAQ Valve Technologies, Inc. Company Overview 53

5.9.1 CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

5.10 Cardio3 BioSciences SA Company Overview 59

5.10.1 Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59

5.11 Cephea Valve Technologies, Inc. Company Overview 60

5.11.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

5.12 Clemson University Company Overview 61

5.12.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61

5.13 Colibri Heart Valve, LLC Company Overview 62

5.13.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.14 CorMatrix Cardiovascular, Inc. Company Overview 70

5.14.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70

5.15 CryoLife, Inc. Company Overview 75

5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75

5.16 Cytograft Tissue Engineering, Inc. Company Overview 77

5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

5.17 Direct Flow Medical, Inc. Company Overview 78

5.17.1 Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78

5.18 Dura Biotech Company Overview 83

5.18.1 Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83

5.19 Edwards Lifesciences Corporation Company Overview 85

5.19.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85

5.20 Emory University Company Overview 106

5.20.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 106

5.21 HighLife SAS Company Overview 108

5.21.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 108

5.22 HLT, Inc. Company Overview 109

5.22.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109

5.23 Innovia LLC Company Overview 112

5.23.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 112

5.24 JenaValve Technology GmbH Company Overview 115

5.24.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 115

5.25 Leman Cardiovascular Company Overview 120

5.25.1 Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview 120

5.26 Mayo Clinic Company Overview 121

5.26.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121

5.27 Medi-Line S.A. Company Overview 122

5.27.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 122

5.28 Medtronic plc Company Overview 123

5.28.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 123

5.29 Meril Life Sciences Pvt. Ltd. Company Overview 135

5.29.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135

5.30 Micro Interventional Devices, Inc. Company Overview 136

5.30.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136

5.31 MicroPort Scientific Corporation Company Overview 138

5.31.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 138

5.32 Mitralix Ltd. Company Overview 142

5.32.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142

5.33 MitrAssist Ltd. Company Overview 143

5.33.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 143

5.34 Mitricares Company Overview 144

5.34.1 Mitricares Pipeline Products & Ongoing Clinical Trials Overview 144

5.35 NaviGate Cardiac Structures, Inc. Company Overview 145

5.35.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145

5.36 Neovasc Inc. Company Overview 146

5.36.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 146

5.37 Peca Labs, Inc. Company Overview 150

5.37.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150

5.38 PolyNova Cardiovascular LLC Company Overview 151

5.38.1 PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview 151

5.39 RegenaGraft Company Overview 152

5.39.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 152

5.40 Revivicor, Inc. Company Overview 153

5.40.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153

5.41 SAS Cormove Company Overview 154

5.41.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 154

5.42 Scientific and Production Center Amphion, LLC Company Overview 155

5.42.1 Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview 155

5.43 Sorin S.p.A. Company Overview 156

5.43.1 Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 156

5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 160

5.44.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 160

5.45 St. Jude Medical, Inc. Company Overview 162

5.45.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162

5.46 Stellenbosch University Company Overview 175

5.46.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 175

5.47 Strait Access Technologies (Pty) Ltd Company Overview 176

5.47.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

5.48 Symetis AG Company Overview 178

5.48.1 Symetis AG Pipeline Products & Ongoing Clinical Trials Overview 178

5.49 Tendyne Medical, Inc. Company Overview 184

5.49.1 Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184

5.50 The Tel Aviv Sourasky Medical Center Company Overview 187

5.50.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 187

5.51 Thubrikar Aortic Valve, Inc. Company Overview 188

5.51.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188

5.52 Tissue Regenix Ltd Company Overview 190

5.52.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 190

5.53 Transcatheter Technologies GmbH Company Overview 193

5.53.1 Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 193

5.54 Twelve, Inc Company Overview 196

5.54.1 Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview 196

5.55 UMC Utrecht Holding BV Company Overview 197

5.55.1 UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview 197

5.56 University College London Company Overview 198

5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 198

5.57 University of California, Irvine Company Overview 199

5.57.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199

5.58 University of Pennsylvania Company Overview 202

5.58.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 202

5.59 Valtech Cardio Ltd. Company Overview 204

5.59.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204

5.60 ValveXchange, Inc. Company Overview 205

5.60.1 ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205

5.61 VueKlar Cardiovascular Ltd. Company Overview 208

5.61.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 208

5.62 Xeltis AG Company Overview 210

5.62.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 210

6 Prosthetic Heart Valves- Recent Developments 211

7 Appendix 306

7.1 Methodology 306

7.2 About GlobalData 308

7.3 Contact Us 309

7.4 Disclaimer 309

1.2 List of Figures

Figure 1: Prosthetic Heart Valves-Pipeline Products by Stage of Development 18

Figure 2: Prosthetic Heart Valves-Pipeline Products by Segment 19

Figure 3: Prosthetic Heart Valves-Pipeline Products by Territory 20

Figure 4: Prosthetic Heart Valves-Pipeline Products by Regulatory Path 21

Figure 5: Prosthetic Heart Valves-Pipeline Products by Estimated Approval Date 22

Figure 6: Prosthetic Heart Valves-Ongoing Clinical Trials 23

1.1 List of Tables

Table 1: Prosthetic Heart Valves-Pipeline Products by Stage of Development 18

Table 2: Prosthetic Heart Valves-Pipeline Products by Segment 19

Table 3: Prosthetic Heart Valves-Pipeline Products by Territory 20

Table 4: Prosthetic Heart Valves-Pipeline Products by Regulatory Path 21

Table 5: Prosthetic Heart Valves-Pipeline Products by Estimated Approval Date 22

Table 6: Prosthetic Heart Valves-Ongoing Clinical Trials 23

Table 7: Prosthetic Heart Valves Companies-Pipeline Products by Stage of Development 24

Table 8: Prosthetic Heart Valves-Pipeline Products by Stage of Development 27

Table 9: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31

Table 10: pTAo-TAVR-Product Status 31

Table 11: pTAo-TAVR-Product Description 31

Table 12: AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 13: AorTech Polymer Valve-Product Status 32

Table 14: AorTech Polymer Valve-Product Description 33

Table 15: Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34

Table 16: Next Generation Device For TAVI-Product Status 34

Table 17: Next Generation Device For TAVI-Product Description 34

Table 18: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 35

Table 19: Two Piece Replacement Heart Valve Apparatus-Product Status 35

Table 20: Two Piece Replacement Heart Valve Apparatus-Product Description 36

Table 21: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37

Table 22: 21 mm Lotus Valve System-Product Status 37

Table 23: 21 mm Lotus Valve System-Product Description 38

Table 24: 23 mm Lotus Valve System-Product Status 38

Table 25: 23 mm Lotus Valve System-Product Description 38

Table 26: 25 mm Lotus Valve System-Product Status 39

Table 27: 25 mm Lotus Valve System-Product Description 39

Table 28: 27 mm Lotus Valve System-Product Status 40

Table 29: 27 mm Lotus Valve System-Product Description 40

Table 30: 29 mm Lotus Valve System-Product Status 41

Table 31: 29 mm Lotus Valve System-Product Description 41

Table 32: Boston Scientific Corporation-Ongoing Clinical Trials Overview 42

Table 33: 23 mm Lotus Valve System-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System (REPRISE I) 43

Table 34: 23 mm Lotus Valve System-REPRISE II: Repositionable Percutaneous Replacement Of Stenotic Aortic Valve Through Implantation Of Lotus Valve System: Evaluation Of Safety And Performance 43

Table 35: 23 mm Lotus Valve System-RESPOND: Repositionable Lotus Valve System-Post Market Evaluation of Real World Clinical Outcomes 43

Table 36: 27 mm Lotus Valve System-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve With the Next Generation Delivery System: REPRISE NGDS 44

Table 37: 25 mm Lotus Valve System-Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System-Randomized Clinical Evaluation (REPRISE III) 45

Table 38: Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46

Table 39: Inovare Valve-Product Status 46

Table 40: Inovare Valve-Product Description 47

Table 41: Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Table 42: Caisson TMVR-Product Status 48

Table 43: Caisson TMVR-Product Description 48

Table 44: Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

Table 45: CARILLON Mitral Contour System-Product Status 49

Table 46: CARILLON Mitral Contour System-Product Description 49

Table 47: Enhanced CARILLON Mitral Contour System-Product Status 50

Table 48: Enhanced CARILLON Mitral Contour System-Product Description 50

Table 49: Cardiac Dimensions, Inc.-Ongoing Clinical Trials Overview 51

Table 50: CARILLON Mitral Contour System-COMPETENT Pilot Study of the CARILLON Mitral Contour System for Treatment of Functional Mitral Regurgitation 52

Table 51: CARILLON Mitral Contour System-Evaluation of Safety and Efficacy of The CARILLON Device 52

Table 52: CARILLON Mitral Contour System-Safety and Efficacy of the CARILLON Mitral Contour System in Reducing Functional Mitral Regurgitation (FMR) Associated with Heart Failure: The REDUCE FMR Trial 52

Table 53: CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

Table 54: Second Generation Transapical Transcatheter Mitral Valve-Product Status 53

Table 55: Second Generation Transapical Transcatheter Mitral Valve-Product Description 53

Table 56: Second Generation Transfemoral Transcatheter Mitral Valve-Product Status 54

Table 57: Second Generation Transfemoral Transcatheter Mitral Valve-Product Description 54

Table 58: Transcatheter Mitral Valve Implantation System-Product Status 55

Table 59: Transcatheter Mitral Valve Implantation System-Product Description 55

Table 60: CardiAQ Valve Technologies, Inc.-Ongoing Clinical Trials Overview 56

Table 61: Second Generation Transapical Transcatheter Mitral Valve-Early Feasibility Study Using the CardiAQ Second-generation Transfemoral (TF) and Transapical (TA) Transcatheter Mitral Valve Implantation (TMVI) Systems 57

Table 62: Second Generation Transfemoral Transcatheter Mitral Valve-Early Feasibility Study Using the CardiAQ Second-generation Transfemoral (TF) and Transapical (TA) Transcatheter Mitral Valve Implantation (TMVI) Systems 58

Table 63: Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59

Table 64: Mitral Valve Neo-chordae-Product Status 59

Table 65: Mitral Valve Neo-chordae-Product Description 59

Table 66: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

Table 67: Mitral Valve Replacement Device-Product Status 60

Table 68: Mitral Valve Replacement Device-Product Description 60

Table 69: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61

Table 70: Mechanical Heart Valve-Product Status 61

Table 71: Mechanical Heart Valve-Product Description 61

Table 72: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62

Table 73: Colibri Aortic Heart Valve-24mm-Product Status 62

Table 74: Colibri Aortic Heart Valve-24mm-Product Description 62

Table 75: Colibri Aortic Heart Valve-21mm-Product Status 63

Table 76: Colibri Aortic Heart Valve-21mm-Product Description 63

Table 77: Colibri Aortic Heart Valve-27mm-Product Status 63

Table 78: Colibri Aortic Heart Valve-27mm-Product Description 64

Table 79: Colibri TAVI Device-Product Status 64

Table 80: Colibri TAVI Device-Product Description 64

Table 81: Custom Delivery System-Product Status 65

Table 82: Custom Delivery System-Product Description 65

Table 83: Delta Aortic Heart Valve-Product Status 65

Table 84: Delta Aortic Heart Valve-Product Description 66

Table 85: Pulmonary Valve-Product Status 66

Table 86: Pulmonary Valve-Product Description 66

Table 87: Sutureless Surgical Aortic Valve-Product Status 67

Table 88: Sutureless Surgical Aortic Valve-Product Description 67

Table 89: Colibri Heart Valve, LLC-Ongoing Clinical Trials Overview 68

Table 90: Colibri TAVI Device-Colibri TAVI System, First Ready-to-Use Transcatheter Heart Valve System: A Prospective, Multicenter, Non-Randomized, Investigational Study 69

Table 91: CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70

Table 92: CorMatrix ECM-Heart Valve Repair-Product Status 70

Table 93: CorMatrix ECM-Heart Valve Repair-Product Description 70

Table 94: CorMatrix ECM-Heart Valve Replacement-Product Status 71

Table 95: CorMatrix ECM-Heart Valve Replacement-Product Description 71

Table 96: CorMatrix ECM Tricuspid Heart Valve-Product Status 71

Table 97: CorMatrix ECM Tricuspid Heart Valve-Product Description 72

Table 98: Pediatric Prosthetic Trileaflet Valve-Product Status 72

Table 99: Pediatric Prosthetic Trileaflet Valve-Product Description 72

Table 100: CorMatrix Cardiovascular, Inc.-Ongoing Clinical Trials Overview 73

Table 101: CorMatrix ECM Tricuspid Heart Valve-Early Feasibility and Investigational Device Exemption Study of CorMatrix ECM Tricuspid Heart Valve 74

Table 102: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75

Table 103: CryoValve SGAV-Product Status 75

Table 104: CryoValve SGAV-Product Description 76

Table 105: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

Table 106: Cytograft Valve-Product Status 77

Table 107: Cytograft Valve-Product Description 77

Table 108: Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78

Table 109: 18F Direct Flow Medical Transcatheter Aortic Valve System-Product Status 78

Table 110: 18F Direct Flow Medical Transcatheter Aortic Valve System-Product Description 79

Table 111: 23mm Direct Flow Medical Transcatheter Aortic Valve System-Product Status 79

Table 112: 23mm Direct Flow Medical Transcatheter Aortic Valve System-Product Description 79

Table 113: Direct Flow Medical, Inc.-Ongoing Clinical Trials Overview 80

Table 114: 18F Direct Flow Medical Transcatheter Aortic Valve System-A Registry To Evaluate The Direct Flow Medical Transcatheter Aortic Valve System For The Treatment Of Patients With Severe Aortic Stenosis 81

Table 115: 18F Direct Flow Medical Transcatheter Aortic Valve System-Direct Flow Medical Transcatheter Aortic Valve System Demonstrates Trial Outcomes in SALUS Trial 81

Table 116: 18F Direct Flow Medical Transcatheter Aortic Valve System-The Direct Flow Medical Transcatheter Aortic Valve Replacement System a US Pivotal Trial 81

Table 117: 18F Direct Flow Medical Transcatheter Aortic Valve System-The Direct Flow Medical TranScatheter Aortic Valve RepLacement System US Feasibility Trial 82

Table 118: Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83

Table 119: Dura Heart Valve-Product Status 83

Table 120: Dura Heart Valve-Product Description 83

Table 121: LowPro Valve-Product Status 84

Table 122: LowPro Valve-Product Description 84

Table 123: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85

Table 124: Edwards CENTERA Valve-Product Status 86

Table 125: Edwards CENTERA Valve-Product Description 86

Table 126: Edwards SAPIEN 3 Valve-Product Status 86

Table 127: Edwards SAPIEN 3 Valve-Product Description 87

Table 128: Edwards SAPIEN Pulmonic Transcatheter Heart Valve-Product Status 87

Table 129: Edwards SAPIEN Pulmonic Transcatheter Heart Valve-Product Description 87

Table 130: Edwards SAPIEN XT Valve-20mm-Product Status 88

Table 131: Edwards SAPIEN XT Valve-20mm-Product Description 88

Table 132: FORTIS Mitral Transcatheter Heart Valve-Product Status 88

Table 133: FORTIS Mitral Transcatheter Heart Valve-Product Description 89

Table 134: GLX Aortic Conduit-Product Status 89

Table 135: GLX Aortic Conduit-Product Description 89

Table 136: INTUITY ELITE-Product Status 90

Table 137: INTUITY ELITE-Product Description 90

Table 138: INTUITY Valve System-Product Status 90

Table 139: INTUITY Valve System-Product Description 91

Table 140: Magna EASE Surgical Valve With GLX-Product Status 91

Table 141: Magna EASE Surgical Valve With GLX-Product Description 91

Table 142: Next Gen CENTERA-Product Status 92

Table 143: Next Gen CENTERA-Product Description 92

Table 144: Next Gen SAPIEN-Product Status 92

Table 145: Next Gen SAPIEN-Product Description 93

Table 146: SAPIEN XT Valve-In-Valve Indication-Product Status 93

Table 147: SAPIEN XT Valve-In-Valve Indication-Product Description 93

Table 148: ZETA Platform-Product Status 94

Table 149: ZETA Platform-Product Description 94

Table 150: Edwards Lifesciences Corporation-Ongoing Clinical Trials Overview 95

Table 151: INTUITY Valve System-Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement 97

Table 152: INTUITY Valve System-Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve 97

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Aegis Surgical Limited, pTAo-TAVR, AorTech International plc, AorTech Polymer Valve, Apica Cardiovascular Limited, Next Generation Device For TAVI, Boston Children's Hospital, Two Piece Replacement Heart Valve Apparatus, Boston Scientific Corporation, 23 mm Lotus Valve System, Boston Scientific Corporation, 25 mm Lotus Valve System, Boston Scientific Corporation, 27 mm Lotus Valve System, Braile Biomedica Ltda., Inovare Valve, Caisson Interventional, LLC, Caisson TMVR, Cardiac Dimensions, Inc., CARILLON Mitral Contour System, Cardiac Dimensions, Inc., Enhanced CARILLON Mitral Contour System, CardiAQ Valve Technologies, Inc., Second Generation Transapical Transcatheter Mitral Valve, CardiAQ Valve Technologies, Inc., Second Generation Transfemoral Transcatheter Mitral Valve, CardiAQ Valve Technologies, Inc., Transcatheter Mitral Valve Implantation System, Cardio3 BioSciences SA, Mitral Valve Neo-chordae, Cephea Valve Technologies, Inc., Mitral Valve Replacement Device, Clemson University, Mechanical Heart Valve, Colibri Heart Valve, LLC, Colibri Aortic Heart Valve - 24mm, Colibri Heart Valve, LLC, Colibri Aortic Heart Valve - 21mm, Colibri Heart Valve, LLC, Colibri Aortic Heart Valve - 27mm, Colibri Heart Valve, LLC, Colibri TAVI Device, Colibri Heart Valve, LLC, Custom Delivery System, Colibri Heart Valve, LLC, Delta Aortic Heart Valve, Colibri Heart Valve, LLC, Pulmonary Valve, Colibri Heart Valve, LLC, Sutureless Surgical Aortic Valve, CorMatrix Cardiovascular, Inc., CorMatrix ECM - Heart Valve Repair, CorMatrix Cardiovascular, Inc., CorMatrix ECM - Heart Valve Replacement, CorMatrix Cardiovascular, Inc., CorMatrix ECM Tricuspid Heart Valve, CorMatrix Cardiovascular, Inc., Pediatric Prosthetic Trileaflet Valve, CryoLife, Inc., CryoValve SGAV, Cytograft Tissue Engineering, Inc., Cytograft Valve, Direct Flow Medical, Inc., 18F Direct Flow Medical Transcatheter Aortic Valve System, Direct Flow Medical, Inc., 23mm Direct Flow Medical Transcatheter Aortic Valve System, Edwards Lifesciences Corporation, Edwards CENTERA Valve, Edwards Lifesciences Corporation, Edwards SAPIEN 3 Valve, Edwards Lifesciences Corporation, Edwards SAPIEN Pulmonic Transcatheter Heart Valve, Edwards Lifesciences Corporation, Edwards SAPIEN XT Valve - 20mm, Edwards Lifesciences Corporation, FORTIS Mitral Transcatheter Heart Valve, Edwards Lifesciences Corporation, GLX Aortic Conduit, Edwards Lifesciences Corporation, INTUITY ELITE, Edwards Lifesciences Corporation, INTUITY Valve System, Edwards Lifesciences Corporation, Magna EASE Surgical Valve With GLX, Edwards Lifesciences Corporation, Next Gen CENTERA, Edwards Lifesciences Corporation, Next Gen SAPIEN, Edwards Lifesciences Corporation, SAPIEN XT - Valve-In-Valve Indication, Edwards Lifesciences Corporation, ZETA Platform, Emory University, MitraCath, HighLife SAS, Transcatheter Mitral Valve Replacement System, HLT, Inc., HLT Transcatheter Valve System, Innovia LLC, Minimally Invasive Synthetic Tri - Leaflet Heart Valve, Innovia LLC, Percutaneous Synthetic Tri - Leaflet Heart Valve, Innovia LLC, Sutured In Synthetic Tri - Leaflet Heart Valve, JenaValve Technology GmbH, JenaValve Transaortic TAVI System, JenaValve Technology GmbH, JenaValve Transapical TAVI System, JenaValve Technology GmbH, JenaValve Transfemoral TAVI System, Leman Cardiovascular, Kalangos Valve, Mayo Clinic, Percutaneous Aortic Valve, Medi-Line S.A., AVATAR Device, Medtronic plc, 23 mm CoreValve Evolut R Transcatheter Valve, Medtronic plc, 26 mm CoreValve Evolut R Transcatheter Valve, Medtronic plc, 29 mm CoreValve Evolut R Transcatheter Valve, Medtronic plc, CoreValve EnVeo R Delivery Catheter System, Medtronic plc, CoreValve Evolut R Recapturable System, Medtronic plc, Engager Transcatheter Aortic Valve Implantation System, Medtronic plc, Native Outflow Tract Transcatheter Pulmonary Valve, Medtronic plc, Next Generation TCV, Meril Life Sciences Pvt. Ltd., Myval Transcatheter Aortic Valve Replacement System, Micro Interventional Devices, Inc., Endovalve, MicroPort Scientific Corporation, Biomaterial Replacement Heart Valve, MicroPort Scientific Corporation, Transcatheter Aortic Valve Implantation System, Mitralix Ltd., MAESTRO, MitrAssist Ltd., MitrAssist Valve, Mitricares, MITRICARES Device, NaviGate Cardiac Structures, Inc., Transcatheter Mitral Valve, Neovasc Inc., Tiara Transcatheter Mitral Valve, Peca Labs, Inc., Masa Valve, PolyNova Cardiovascular LLC, Trileaflet Polymeric Prosthetic Heart Valve, RegenaGraft, Synthetic Heart Valve, Revivicor, Inc., Heart Valve, SAS Cormove, CORMOVE Percutaneous Aortic Valve, Scientific and Production Center Amphion, LLC, Artificial Venous Valve, Sorin S.p.A., Perceval S Aortic Heart Valve, Sorin S.p.A., Percutaneous Mitral Valve Replacement Device, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Artificial Heart Valve, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Tissue Based Cardiac Valve, St. Jude Medical, Inc., Masters HP Series 15mm Mechanical Heart Valve, St. Jude Medical, Inc., Portico Transapical Aortic Heart Valve System - 23 mm, St. Jude Medical, Inc., Portico Transcatheter Aortic Valve Implantation System, St. Jude Medical, Inc., Portico Transfemoral Aortic Heart Valve System - 23 mm, St. Jude Medical, Inc., Portico Transfemoral Aortic Heart Valve System - 25mm, St. Jude Medical, Inc., Portico Transfemoral Aortic Heart Valve System - 27 mm, St. Jude Medical, Inc., Portico Transfemoral Aortic Heart Valve System - 29mm, St. Jude Medical, Inc., Subclavian Delivery System, Stellenbosch University, Percutaneous Heart Valve, Strait Access Technologies (Pty) Ltd, SATH Heart Valve, Strait Access Technologies (Pty) Ltd, Transcatheter Valve Delivery Device, Symetis AG, Acurate TA, Symetis AG, ACURATE TAo, Symetis AG, Acurate TF, Tendyne Medical, Inc., Tendyne Bioprosthetic Mitral Valve Implantation System, The Tel Aviv Sourasky Medical Center, Mitral Valve Implantation Device, Thubrikar Aortic Valve, Inc., 20F Optimum TAV Delivery Catheter, Thubrikar Aortic Valve, Inc., Optimum TAVI System, Tissue Regenix Ltd, dCELL Bovine Heart Valve, Tissue Regenix Ltd, dCELL Porcine Aortic Heart Valve, Tissue Regenix Ltd, dCELL Porcine Pulmonary Heart Valve, Transcatheter Technologies GmbH, Transapical Trinity Aortic Valve Implantation System, Transcatheter Technologies GmbH, Transfemoral Trinity Aortic Valve Implantation System, Transcatheter Technologies GmbH, Tresillo System, Twelve, Inc, Mitral Valve, UMC Utrecht Holding BV, Transcatheter Heart Valve, University College London, Transcatheter Aortic Valve, University of California, Irvine, Bileaflet Bioprosthetic Mitral Valve, University of California, Irvine, Bovine Pericardium Heart Valve, University of California, Irvine, Heart Valve Leaflets, Valtech Cardio Ltd., Valtech Cardiovalve, ValveXchange, Inc., Vanguard System, ValveXchange, Inc., Vitality Exchangeable Valve System, ValveXchange, Inc., VXi Vanguard II, VueKlar Cardiovascular Ltd., MR-Enhancing Percutaneous Heart Valve, Xeltis AG, QTIS Heart Valve

select a license

Single User License
USD 4000 INR 258240
Site License
USD 8000 INR 516480
Corporate User License
USD 12000 INR 774720

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com